Literature DB >> 27101923

Naïve and memory B cells exhibit distinct biochemical responses following BCR engagement.

Leen Moens1, Alisa Kane1,2, Stuart G Tangye1,2.   

Abstract

Immunological memory is characterized by the rapid reactivation of memory B cells that produce large quantities of high-affinity antigen-specific antibodies. This contrasts the response of naïve B cells, and the primary immune response, which is much slower and of lower affinity. Memory responses are critical for protection against infectious diseases and form the basis of most currently available vaccines. Although we have known about the phenomenon of long-lived memory for centuries, the biochemical differences underlying these diverse responses of naïve and memory B cells is incompletely resolved. Here we investigated the nature of B-cell receptor (BCR) signaling in human splenic naïve, IgM(+) memory and isotype-switched memory B cells following multivalent BCR crosslinking. We observed comparable rapid and transient phosphorylation kinetics for proximal (phosphotyrosine and spleen tyrosine kinase) and propagation (B-cell linker, phospholipase Cγ2) signaling components in these different B-cell subsets. However, the magnitude of activation of downstream components of the BCR signaling pathway were greater in memory compared with naïve cells. Although no differences were observed in the magnitude of Ca(2+) mobilization between subsets, IgM(+) memory B cells exhibited a more rapid Ca(2+) mobilization and a greater depletion of the Ca(2+) endoplasmic reticulum stores, while IgG(+) memory B cells had a prolonged Ca(2+) uptake. Collectively, our findings show that intrinsic signaling features of B-cell subsets contribute to the robust response of human memory B cells over naïve B cells. This has implications for our understanding of memory B-cell responses and provides a framework to modulate these responses in the setting of vaccination and immunopathologies, such as immunodeficiency and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27101923     DOI: 10.1038/icb.2016.41

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  65 in total

Review 1.  Control systems and decision making for antibody production.

Authors:  Christopher C Goodnow; Carola G Vinuesa; Katrina L Randall; Fabienne Mackay; Robert Brink
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

2.  Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation.

Authors:  Kohei Kometani; Rinako Nakagawa; Ryo Shinnakasu; Tomohiro Kaji; Andrei Rybouchkin; Saya Moriyama; Koji Furukawa; Haruhiko Koseki; Toshitada Takemori; Tomohiro Kurosaki
Journal:  Immunity       Date:  2013-07-11       Impact factor: 31.745

3.  Quiescent memory B cells in human peripheral blood co-express bcl-2 and bcl-x(L) anti-apoptotic proteins at high levels.

Authors:  F Bovia; A C Nabili-Tehrani; C Werner-Favre; M Barnet; V Kindler; R H Zubler
Journal:  Eur J Immunol       Date:  1998-12       Impact factor: 5.532

4.  Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses.

Authors:  A M Oliver; F Martin; G L Gartland; R H Carter; J F Kearney
Journal:  Eur J Immunol       Date:  1997-09       Impact factor: 5.532

5.  Antigen receptor proximal signaling in splenic B-2 cell subsets.

Authors:  X Li; F Martin; A M Oliver; J F Kearney; R H Carter
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

6.  Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells.

Authors:  Santi Suryani; David A Fulcher; Brigitte Santner-Nanan; Ralph Nanan; Melanie Wong; Peter J Shaw; John Gibson; Andrew Williams; Stuart G Tangye
Journal:  Blood       Date:  2009-11-17       Impact factor: 22.113

7.  Antigen-selected, immunoglobulin-secreting cells persist in human spleen and bone marrow.

Authors:  Julia I Ellyard; Danielle T Avery; Tri Giang Phan; Nathan J Hare; Philip D Hodgkin; Stuart G Tangye
Journal:  Blood       Date:  2003-12-30       Impact factor: 22.113

8.  Rapid Proliferation and Differentiation of a Subset of Circulating IgM Memory B Cells to a CpG/Cytokine Stimulus In Vitro.

Authors:  Camilo Vásquez; Manuel A Franco; Juana Angel
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

9.  The immunoglobulin tail tyrosine motif upgrades memory-type BCRs by incorporating a Grb2-Btk signalling module.

Authors:  Niklas Engels; Lars M König; Wiebke Schulze; Daniel Radtke; Kanika Vanshylla; Johannes Lutz; Thomas H Winkler; Lars Nitschke; Jürgen Wienands
Journal:  Nat Commun       Date:  2014-11-21       Impact factor: 14.919

10.  Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.

Authors:  Keisuke Horikawa; Stephen W Martin; Sarah L Pogue; Karlee Silver; Kaiman Peng; Kiyoshi Takatsu; Christopher C Goodnow
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

View more
  10 in total

1.  Are B cells altered in the decidua of women with preterm or term labor?

Authors:  Yaozhu Leng; Roberto Romero; Yi Xu; Jose Galaz; Rebecca Slutsky; Marcia Arenas-Hernandez; Valeria Garcia-Flores; Kenichiro Motomura; Sonia S Hassan; Andrea Reboldi; Nardhy Gomez-Lopez
Journal:  Am J Reprod Immunol       Date:  2019-03-29       Impact factor: 3.886

2.  Induction of human dendritic cell maturation by naïve and memory B-cell subsets requires different activation stimuli.

Authors:  Mohan S Maddur; Srini V Kaveri; Jagadeesh Bayry
Journal:  Cell Mol Immunol       Date:  2018-03-22       Impact factor: 11.530

3.  Conserved Epigenetic Programming and Enhanced Heme Metabolism Drive Memory B Cell Reactivation.

Authors:  Madeline J Price; Christopher D Scharer; Anna K Kania; Troy D Randall; Jeremy M Boss
Journal:  J Immunol       Date:  2021-02-24       Impact factor: 5.422

4.  Optimal evolutionary decision-making to store immune memory.

Authors:  Oskar H Schnaack; Armita Nourmohammad
Journal:  Elife       Date:  2021-04-28       Impact factor: 8.140

5.  Evaluation of Antigen-Specific IgM and IgG Production during an In Vitro Peripheral Blood Mononuclear Cell Culture Assay.

Authors:  Yoshiko Matsuda; Ryoichi Imamura; Shiro Takahara
Journal:  Front Immunol       Date:  2017-07-10       Impact factor: 7.561

Review 6.  Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.

Authors:  Walaa Darwiche; Brigitte Gubler; Jean-Pierre Marolleau; Hussein Ghamlouch
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

7.  Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains.

Authors:  Ivette A Nuñez; Michael A Carlock; James D Allen; Simon O Owino; Krissy K Moehling; Patricia Nowalk; Michael Susick; Kensington Diagle; Kristen Sweeney; Sophia Mundle; Thorsten U Vogel; Simon Delagrave; Moti Ramgopal; Richard K Zimmerman; Harry Kleanthous; Ted M Ross
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

8.  Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.

Authors:  Agnieszka Szymula; Richard D Palermo; Amr Bayoumy; Ian J Groves; Mohammed Ba Abdullah; Beth Holder; Robert E White
Journal:  PLoS Pathog       Date:  2018-02-20       Impact factor: 6.823

9.  Endogenous Nur77 Is a Specific Indicator of Antigen Receptor Signaling in Human T and B Cells.

Authors:  Judith F Ashouri; Arthur Weiss
Journal:  J Immunol       Date:  2016-12-09       Impact factor: 5.422

10.  Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.

Authors:  Lei Wang; Ming Ni; Angela Hückelhoven-Krauss; Leopold Sellner; Jean-Marc Hoffmann; Brigitte Neuber; Thomas Luft; Ute Hegenbart; Stefan Schönland; Christian Kleist; Martin Sill; Bao-An Chen; Patrick Wuchter; Volker Eckstein; William Krüger; Inken Hilgendorf; Ronit Yerushalmi; Arnon Nagler; Carsten Müller-Tidow; Anthony D Ho; Peter Dreger; Michael Schmitt; Anita Schmitt
Journal:  Front Immunol       Date:  2018-10-08       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.